Delivery Order SPE2DB22D3004-SPE2DB25FQ74F
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, by the Defense Logistics Agency for $50,225.55 to supply Biktarvy 50-200-25 mg tablets in quantities of 30. This firm fixed-price delivery order, which is not set-aside designated, is expected to be completed by August 8, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a continuation of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count unit dose packages) valued at $28,563.74. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency (DLA), a defense agency responsible for supplying pharmaceuticals and medical materiel to military health systems. The contract is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $62,597.51 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a relatively small transaction within AmerisourceBergen's broader federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency (DLA) for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $12,635.27, is set to be completed by August 13, 2025, and represents performance at the company's Conshohocken facility. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $39.8K delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 17, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $5,600.87 and an ultimate completion date of September 2, 2025. The contract is not set-aside and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract carries a ceiling value of $29,348.41 and features firm fixed pricing, with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,117.08 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $66,709.27, was competitively awarded with no set-aside designation and is scheduled for completion by August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) valued at $1,548.16 for Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract is classified as a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and no set-aside designation. The award serves the federal medical supply chain supporting military and veteran healthcare systems through...